Provigate, Inc.
Tokyo, JP · 1 known investors
Provigate develops a low/non-invasive, low-cost home glucose monitoring service based on weekly glycated albumin (GA) testing from finger-prick blood or saliva samples via mail-in and point-of-care testing, paired with a coaching app and a remote monitoring dashboard for clinicians. It targets people with diabetes and those at risk, aiming to support behavior change for blood-sugar management.
BiotechDigital HealthMedical Devices